Stability Protocol Design for Monoclonal Antibodies
Stability Protocol Design for Monoclonal Antibodies Designing Stability Protocols for Monoclonal Antibodies: Regulatory and Scientific Best Practices Monoclonal antibodies (mAbs) are among the most complex and sensitive drug products in the biopharmaceutical landscape. Their large molecular structure, post-translational modifications, and susceptibility to environmental stress make stability protocol design a critical component of product development and…
Read More “Stability Protocol Design for Monoclonal Antibodies” »